NOVARTIS INDIA LTD. - 500672 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Novartis India Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.30-01-2019
30-01-2019
Novartis India Ltd - 500672 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Novartis India Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.29-01-2019
NOVARTIS INDIA LTD. - 500672 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1340 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer17-01-2019
NOVARTIS INDIA LTD. - 500672 - Shareholding for the Period Ended December 31, 2018
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here16-01-2019
Novartis India Ltd - 500672 - Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Would Like To Inform You That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday, February 4, 2019; Inter-Alia To Consider Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2018.
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 4, 2019; inter-alia to consider unaudited financial results of the Company for the third quarter and nine months ended December 31, 2018. Further, pursuant to the Code of conduct to regulate, monitor and report share trading by Insiders, the trading window for dealing in the securities of the Company would remain closed from January 1, 2019 to February 6, 2019 (both days inclusive). Further, a copy of this notice will be published in the selected newspapers and will be made available on the website of the Company www.novartis.in.31-12-2018
Company news: Novartis India
Novartis India on Wednesday said its Vice-Chairman and Managing Director Milan Paleja has decided to step down from the company from May 31, 2019. "Pa05-12-2018
Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, Mr Milan Paleja, Vice Chairman & Managing Director of the Company has informed the Board of Directors today of his decision to step down as the Vice Chairman & Managing Director, effective close of business hours on May 31, 2019 for embracing challenges outside of Novartis....05-12-2018
Novartis gets European nod to gene therapy for retinal disease
Novartis on Friday said it had received European Union approval for its Luxturna gene therapy to restore sight to people with a rare retinal disease.23-11-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sirs, In continuation to our letter dated November 13, 2018 please find enclosed copies of Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2018 that was published in the Financial Express and Navshakti on November 14, 2018. The same has been made available on the website of the Company www.novartis.in. Thanking you Yours sincerely, For Novartis India Limited14-11-2018
Financial Results For The Second Quarter And Half Year Ended September 30, 2018
Dear Sirs, We refer to our letter dated September 28, 2018, informing you of our Board Meeting that was scheduled for today. Please note that the Board of Directors of Novartis India Limited met today and considered financial results of the Company for second quarter and half year ended September 30, 2018. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 3.20 p.m....13-11-2018